Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
1.650
+0.060 (3.77%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Evaxion Biotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 5.95 | 5.58 | 13.18 | 32.17 | 5.83 | Upgrade
|
| Cash & Short-Term Investments | 5.95 | 5.58 | 13.18 | 32.17 | 5.83 | Upgrade
|
| Cash Growth | 6.61% | -57.65% | -59.01% | 451.35% | -38.97% | Upgrade
|
| Other Receivables | 1.86 | 1.08 | 1.31 | 1.9 | 2.21 | Upgrade
|
| Receivables | 1.86 | 1.08 | 1.31 | 1.9 | 2.21 | Upgrade
|
| Prepaid Expenses | 0.96 | 1.69 | 2.49 | 0.64 | 1.18 | Upgrade
|
| Other Current Assets | - | - | - | - | 1.73 | Upgrade
|
| Total Current Assets | 8.77 | 8.35 | 16.99 | 34.71 | 10.95 | Upgrade
|
| Property, Plant & Equipment | 3.51 | 4.34 | 4.68 | 5.17 | 0.22 | Upgrade
|
| Other Intangible Assets | - | - | - | 0.09 | 0.1 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | - | 0.26 | Upgrade
|
| Other Long-Term Assets | 0.21 | 0.2 | 0.37 | 0.19 | 0.43 | Upgrade
|
| Total Assets | 12.49 | 12.89 | 22.03 | 40.16 | 11.97 | Upgrade
|
| Accounts Payable | 2.97 | 2.69 | 2.09 | 2.85 | 3.67 | Upgrade
|
| Accrued Expenses | 0.86 | 0.89 | 0.35 | 0.99 | 1.05 | Upgrade
|
| Current Portion of Long-Term Debt | 0.16 | 0.16 | 0.14 | 0.13 | - | Upgrade
|
| Current Portion of Leases | 0.31 | 0.33 | 0.3 | 0.31 | 0.02 | Upgrade
|
| Other Current Liabilities | 0.07 | 3.02 | 0.89 | 0.05 | 0.18 | Upgrade
|
| Total Current Liabilities | 4.37 | 7.08 | 3.76 | 4.32 | 4.93 | Upgrade
|
| Long-Term Debt | 8.01 | 8.49 | 7.86 | 1.04 | - | Upgrade
|
| Long-Term Leases | 1.62 | 1.9 | 1.95 | 2.21 | - | Upgrade
|
| Other Long-Term Liabilities | 0.14 | 0.15 | 0.14 | 0.15 | - | Upgrade
|
| Total Liabilities | 14.14 | 17.62 | 13.72 | 7.73 | 4.93 | Upgrade
|
| Common Stock | 10.52 | 5.9 | 3.89 | 3.76 | 2.65 | Upgrade
|
| Additional Paid-In Capital | 95.94 | 87.45 | 80.73 | 80.43 | 31.44 | Upgrade
|
| Retained Earnings | -118.54 | -107.97 | -85.85 | -50.43 | -27.28 | Upgrade
|
| Comprehensive Income & Other | 10.43 | 9.89 | 9.54 | -1.32 | 0.23 | Upgrade
|
| Shareholders' Equity | -1.65 | -4.73 | 8.3 | 32.44 | 7.04 | Upgrade
|
| Total Liabilities & Equity | 12.49 | 12.89 | 22.03 | 40.16 | 11.97 | Upgrade
|
| Total Debt | 10.1 | 10.87 | 10.26 | 3.69 | 0.02 | Upgrade
|
| Net Cash (Debt) | -4.15 | -5.29 | 2.93 | 28.48 | 5.81 | Upgrade
|
| Net Cash Growth | - | - | -89.71% | 389.78% | -38.95% | Upgrade
|
| Net Cash Per Share | -3.87 | -9.67 | 6.20 | 73.04 | 18.83 | Upgrade
|
| Filing Date Shares Outstanding | 6.27 | 1.04 | 0.48 | 0.46 | 0.38 | Upgrade
|
| Total Common Shares Outstanding | 1.4 | 0.76 | 0.48 | 0.46 | 0.32 | Upgrade
|
| Working Capital | 4.4 | 1.27 | 13.22 | 30.38 | 6.02 | Upgrade
|
| Book Value Per Share | -1.18 | -6.24 | 17.20 | 69.90 | 21.72 | Upgrade
|
| Tangible Book Value | -1.65 | -4.73 | 8.3 | 32.34 | 6.94 | Upgrade
|
| Tangible Book Value Per Share | -1.18 | -6.24 | 17.20 | 69.70 | 21.42 | Upgrade
|
| Machinery | 1.36 | 1.44 | 1.37 | 1.23 | 0.26 | Upgrade
|
| Leasehold Improvements | 1.66 | 1.75 | 1.63 | 1.57 | - | Upgrade
|
Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.